Main > PEDIATRICS > Endocrinology/Metabolics > Severe Primary IGF-I Deficiency > Treatment > Mecasermin/rhIGFBP-3 Complex > Co.: USA. I. (Brand Inj./Patents)

---

Co.: USA. I. (Brand Inj./Patents)'s subsections
Company
Patent>Catabolic Condition>Treat.
Patent>Formulation
Patent>High Dose Therapy Method
Patent>Production Method
Patent>Total USA No.: 5
Patent>UpDate: 12.18.07
Status>USA>Approved: 12.05
TradeMark

Co.: USA. I. (Brand Inj./Patents)'s products
This section has no products